Published in J Surg Oncol on January 01, 1980
Primary Pulmonary Malignant Melanoma: Report of an Important Entity and Literature Review. Case Rep Oncol Med (2017) 0.83
Patient preference and pharmacokinetics of oral modulated UFT versus intravenous fluorouracil and leucovorin: a randomised crossover trial in advanced colorectal cancer. Eur J Cancer (2002) 2.34
Response to mesna, doxorubicin, ifosfamide, and dacarbazine in 108 patients with metastatic or unresectable sarcoma and no prior chemotherapy. J Clin Oncol (1989) 1.69
Giant melanoma of the inner thigh: a homeopathic life-threatening negligence. Ann Plast Surg (1991) 1.48
Elimination of graft-versus-host disease by in-vitro depletion of alloreactive lymphocytes with a monoclonal rat anti-human lymphocyte antibody (CAMPATH-1). Lancet (1984) 1.31
Low PSA metastatic androgen- independent prostate cancer. Eur Urol (2000) 1.20
PAGET'S DISEASE AND MALE BREAST CANCER. Isr Med Assoc J (2015) 1.08
Pharmacokinetic and imaging studies in patients receiving a formulation of liposome-associated adriamycin. Br J Cancer (1991) 1.02
The rate of the 6174delT founder Jewish mutation in BRCA2 in patients with non-colonic gastrointestinal tract tumours in Israel. Br J Cancer (2001) 1.01
Prognostic factors for local control of early glottic cancer: the Rabin Medical Center retrospective study on 207 patients. Int J Radiat Oncol Biol Phys (1999) 0.99
Systemic administration of doxorubicin-containing liposomes in cancer patients: a phase I study. Eur J Cancer Clin Oncol (1989) 0.98
Second neoplasms in patients with Merkel cell carcinoma. Cancer (2001) 0.98
The role of radiation therapy and chemotherapy in the treatment of Merkel cell carcinoma. Cancer (1997) 0.96
5-Fluorouracil, doxorubicin (adriamycin) and mitomycin-C (FAM) in advanced gastric cancer: observations on response, patient characteristics, myelosuppression and delivered dosage. Oncology (1989) 0.92
Reversal of ergotamine-induced arteriospasm by mechanical intra-arterial dilatation. Lancet (1980) 0.91
Decline in pulmonary function in patients with breast cancer receiving dose-dense chemotherapy: a prospective study. Ann Oncol (2009) 0.91
Congenital aplasia of the deep veins of lower extremities in children: the role of ascending functional phlebography. Surgery (1986) 0.90
The use of a balloon catheter in the treatment of an iatrogenic pseudo-aneurysm of the subclavian artery. J Cardiovasc Surg (Torino) (1983) 0.90
Early development of vaginal shortening during radiation therapy for endometrial or cervical cancer. Int J Gynecol Cancer (2001) 0.90
Phase I and clinical pharmacological evaluation of aphidicolin glycinate. J Natl Cancer Inst (1991) 0.90
Collateral pathways in inferior vena caval obstruction in children, including the cavo-portal route. Pediatr Radiol (1981) 0.89
The behavior of reticulin fibers in and around melanomas. J Cutan Pathol (1978) 0.89
Tritiated thymidine labeling index and response in human breast cancer. J Natl Cancer Inst (1979) 0.89
Gemcitabine in patients with advanced malignant melanoma or gastric cancer: phase II studies of the EORTC Early Clinical Trials Group. Ann Oncol (1994) 0.88
Effect of natural beta-carotene supplementation in children exposed to radiation from the Chernobyl accident. Radiat Environ Biophys (1998) 0.88
Correlation of erythrocyte and plasma levels of zinc, copper, and iron with evidence of metastatic spread in cancer patients. Cancer (1985) 0.87
Topical Biafine and Lipiderm for the prevention of radiation dermatitis: a randomized prospective trial. Oncol Rep (2001) 0.87
Classic Kaposi sarcoma: experience at Rabin Medical Center in Israel. Am J Clin Oncol (1998) 0.87
Phase II studies of docetaxel in the treatment of various solid tumours. EORTC Early Clinical Trials Group and the EORTC Soft Tissue and Bone Sarcoma Group. Eur J Cancer (1995) 0.86
Colorectal cancer in young patients in Israel: a distinct clinicopathological entity? World J Surg (2010) 0.86
Radiation-induced aneurysm of the basilar artery--a case report. Angiology (1987) 0.86
Phase I and clinical pharmacology study of intravenous flavone acetic acid (NSC 347512). Cancer Res (1988) 0.85
Isolated pericardial metastasis of parotid tumor origin. Head Neck Surg (1982) 0.85
Pericardial effusion as first evidence of malignancy in bronchogenic carcinoma. J Surg Oncol (1982) 0.84
A sequential four-drug chemotherapy and biotherapy with interferon alpha and GM-CSF--an innovative protocol for the treatment of metastatic melanoma. Cancer Biother Radiopharm (1998) 0.83
Prediction of outcome in locally advanced breast cancer by post-chemotherapy nodal status and baseline serum tumour markers. Br J Cancer (2002) 0.83
Sex hormone binding globulin (SHBG) in breast cancer: a correlation with obesity but not with estrogen receptor status. Eur J Cancer Clin Oncol (1984) 0.83
Anatomy of the postauricular island "revolving door" flap ("flip-flop" flap). Ann Plast Surg (1997) 0.82
Prognosis of patients with recurrent laryngeal carcinoma. Head Neck (2001) 0.82
Reappraisal of some dosage adjustment guidelines. Cancer Treat Rep (1987) 0.82
Phenotypic characteristics of colo-rectal cancer in I1307K APC germline mutation carriers compared with sporadic cases. Br J Cancer (2001) 0.82
Thyroid carcinoma induced by irradiation for Hodgkin's disease. Report of a case. Acta Radiol Oncol Radiat Phys Biol (1978) 0.81
Familial benign chronic pemphigus appearing as leukoplakia of the vulva. Int J Dermatol (1984) 0.81
Second primary lung carcinoma. J Surg Oncol (1980) 0.81
Combined 5-fluorouracil (5-FU) and radiation therapy following resection of locally advanced gastric carcinoma. J Surg Oncol (1986) 0.81
Tailoring treatment for classical Kaposi's sarcoma: comprehensive clinical guidelines. Int J Oncol (1999) 0.80
Multiple arterial aneurysms. J Pediatr Surg (1983) 0.80
Coronary artery operation in patients after breast cancer therapy. Ann Thorac Surg (1998) 0.80
Elimination of graft versus host disease in matched allogeneic leukemic transplant recipients using CAMPATH-1. Adv Exp Med Biol (1985) 0.80
Genetic analysis of the APC gene regions involved in attenuated APC phenotype in Israeli patients with early onset and familial colorectal cancer. Br J Cancer (2001) 0.80
Aminoglutethimide-induced leukopenia: a case report and review of the literature. Oncology (1984) 0.79
Development and decay of systemic thermotolerance in rats. Cancer Res (1984) 0.79
Megavoltage radiotherapy using water bolus in the treatment of Kaposi's sarcoma. Int J Radiat Oncol Biol Phys (1986) 0.79
Parotid gland metastatic carcinoma of breast origin. J Surg Oncol (1982) 0.79
Transluminal dilatation of the subclavian artery. Cardiovasc Intervent Radiol (1985) 0.79
Aneurysm of the lingual artery. Neuroradiology (1983) 0.79
Adjuvant treatment of high-risk stage II breast cancer with doxorubicin followed by high-dose chemotherapy and autologous stem-cell transplantation: a single-institution experience with 132 consecutive patients. Bone Marrow Transplant (2003) 0.78
Comment on "Perhaps not everyone knows that...", (Ann Oncol 2001; 12: 1186). Ann Oncol (2002) 0.78
HLA-DR and beta 2 microglobulin expression in medullary and atypical medullary carcinoma of the breast: histopathologically similar but biologically distinct entities. J Clin Pathol (2000) 0.78
Cyclophosphamide, adriamycin, DTIC and vincristine with methotrexate in the treatment of advanced soft tissue sarcomas. Isr J Med Sci (1989) 0.78
Antiandrogen withdrawal syndrome with cyproterone acetate. Urology (1998) 0.78
New approaches for the prevention of rejection and graft-vs.-host disease in clinical bone marrow transplantation. Isr J Med Sci (1986) 0.78
Radiation therapy for locally advanced breast cancer: prognostic factors and complication rate. Eur J Surg Oncol (1990) 0.78
The use of cyclophosphamide, methotrexate, and 5-fluorouracil in the treatment of Merkel cell carcinoma. Am J Clin Oncol (1993) 0.78
Adjuvant chemotherapy with and without radiotherapy in stage II breast cancer. Biomed Pharmacother (1988) 0.78
Second-line chemotherapy with mitoxantrone as a single agent in metastatic breast cancer. J Chemother (1993) 0.78
The treatment of advanced Merkel cell carcinoma. A multimodality chemotherapy and radiation therapy treatment approach. J Dermatol Surg Oncol (1993) 0.78
In vitro irradiation effects on hardness and solubility of human enamel and dentin pretreated with fluoride. Clin Prev Dent (1986) 0.78
Metastatic maxillary sinus melanoma treated by local excision and brachytherapy. J Otolaryngol (1989) 0.77
Modulatory effect of fluoride and irradiation on rat molar rate of wear. Bull Group Int Rech Sci Stomatol Odontol (1991) 0.77
Oral etoposide for Merkel cell carcinoma in patients previously treated with intravenous etoposide. Am J Clin Oncol (2000) 0.77
Radiation treatment for ductal carcinoma in situ (DCIS): is a boost to the tumor bed necessary? Neoplasma (2006) 0.77
Role of radiation therapy in the management of cutaneous malignant melanoma. Am J Clin Oncol (1999) 0.77
Combined modality treatment for stage III ovarian carcinoma. Radiother Oncol (1985) 0.77
Thoracic outlet syndrome: a multidisciplinary problem with a perspective for microsurgical management without rib resection. Acta Neurochir Suppl (2007) 0.77
The effect of postoperative radiotherapy on the feasibility of optimal dose adjuvant CMF chemotherapy in stage II breast carcinoma. Int J Radiat Oncol Biol Phys (1983) 0.77
Natural beta-carotene and whole body irradiation in rats. Radiat Environ Biophys (1996) 0.77
Pleural effusion in breast cancer: influence upon clinical course and survival. Chemioterapia (1986) 0.76
Toxicity of adjuvant high-dose interferon-alpha-2b in patients with cutaneous melanoma at high risk of recurrence. Oncol Rep (1999) 0.76
Spontaneous intracranial hemorrhage in a patient with ovarian carcinoma. Gynecol Oncol (1985) 0.76
Megestrol acetate in advanced breast carcinoma after failure to tamoxifen and/or aminoglutethimide. Oncology (1994) 0.76
Total lymphoid irradiation in refractory systemic lupus erythematosus. Ann Intern Med (1986) 0.76
Tolerance to donor-type skin in the recipient of a bone marrow allograft. Treatment of skin ulcers in chronic graft-versus-host disease with skin grafts from the bone marrow donor. Transplantation (1985) 0.76
Serum transcobalamin II levels in breast carcinoma patients. Isr J Med Sci (1982) 0.76
The use of total lymphoid irradiation (TLI) for prevention of rejection of T-lymphocyte depleted bone marrow allografts in non-malignant hematological disorders. Transplant Proc (1989) 0.76
Allogeneic bone marrow transplantation without graft-v-host disease: true tolerance of graft against the host through depletion of donor T lymphocytes pregrafting in malignant and nonmalignant disorders. Transplant Proc (1987) 0.76
Role of the vascular laboratory in the diagnosis of aortic arch occlusive disease: Screening of 2000 patients. Cardiovasc Dis (1981) 0.75
Doxorubicin-based chemotherapy in the elderly. Ann Oncol (2001) 0.75
Allogeneic human liposomal melanoma vaccine with or without IL-2 in metastatic melanoma patients: clinical and immunobiological effects. Cancer Biother (1995) 0.75
Liver metastases from colorectal cancer: regional intra-arterial treatment following failure of systemic chemotherapy. Br J Cancer (2001) 0.75
The use of total lymphoid irradiation for allogeneic bone marrow transplantation in animals and man. Surv Immunol Res (1985) 0.75
[Immunosuppression and induction of tolerance by fractionated total lymphoid irradiation]. Harefuah (1985) 0.75
Malignant acanthosis nigricans. Arch Dermatol (1978) 0.75
[T lymphomas in the skin]. Harefuah (1978) 0.75
[Chemotherapy of malignant scalp angioendothelioma]. Z Hautkr (1978) 0.75